Brief: Theranexus End-June Cash Position Up At EUR 13.5 Mln

Thx Pharma SA

08/07/2021 18:19

July 8 (Reuters) - Theranexus SA  ALTHX.PA :
    * PUBLISHES ITS CASH POSITION AS OF 30 JUNE 2021 AND PRESENTS AN UPDATE ON
PROGRESS OF ITS MAIN PROGRAMS
    * TOTAL AVAILABLE FUNDS ON 30 JUNE 2021 STOOD AT EUR 13.5 M, COMPARED WITH
EUR
11.2 M ON 31 DECEMBER 2020
    * IN H2, CO SHOULD BENEFIT FROM 2020 RESEARCH TAX CREDIT  FOR SUM OF EUR 1.0
M,
AND FROM BPIFRANCE FUNDING FOR AN AMOUNT OF EUR 1.0 M
    * DISCUSSIONS WITH SEVERAL POTENTIAL INDUSTRIAL PARTNERS HAVE NOT YET
YIELDED AN
AGREEMENT AS AT 30 JUNE AND ARE STILL CONTINUING
    * CO IS FINALIZING CLINICAL TRIAL AUTHORIZATION APPLICATION TO FDA, WITH
VIEW TO
START CLINICAL TRIALS IN US BY END OF YEAR

Source text for Eikon:  ID:nNDL5zqQjq 
Further company coverage:  ALTHX.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))